Synergy between the iron chelator deferoxamine and the antimicrobial agents gentamicin, chloramphenicol, cefalothin, cefotiam and cefsulodin
- 1 October 1983
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 2 (5) , 432-438
- https://doi.org/10.1007/bf02013900
Abstract
Synergy between the iron chelator deferoxamine in the presence or absence of ascorbic acid and gentamicin, chloramphenicol, cephalothin, cefotiam or cefsulodin, used againstStaphylococcus aureus, Staphylococcus epidermidis, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis and species ofSalmonella, Enterobacter, Pseudomonas andProvidencia, was determined by measuring the effect of the drugs and combination of drugs on growth of the bacteria in an automated turbidimeter. The combination of drugs was considered to be synergistic when the growth inhibiting effect of the combination was greater than that of the combined action of each of the drugs separately. Deferoxamine plus ascorbic acid together with either gentamicin or cefsulodin showed synergy in 10 out of 10, and 5 out of 6 cultures respectively, whereas deferoxamine plus ascorbic acid with chloramphenicol, cephalothin or cefotiam was synergistic in 6 out of 14, 5 out of 11, and 3 out of 6 cultures. This synergistic effect was much lower when microorganisms were incubated with deferoxamine combined with the various antibiotics but without ascorbic acid. Ascorbic acid alone had no synergistic effect. When deferoxamine was saturated with iron, its antibacterial effect was completely abolished.Keywords
This publication has 22 references indexed in Scilit:
- Evolution of biological iron binding centersPublished by Springer Nature ,2005
- Inhibition of bacterial multiplication by the iron chelator deferoxamine: Potentiating effect of ascorbic acidEuropean Journal of Clinical Microbiology & Infectious Diseases, 1983
- Listeria monocytogenes meningitis and decreased phagocytosis associated with iron overload.BMJ, 1982
- Vitamin C and IronNew England Journal of Medicine, 1981
- The critical role of iron in host-bacterial interactions.Journal of Clinical Investigation, 1978
- Continuous Subcutaneous Administration of Deferoxamine in Patients with Iron OverloadNew England Journal of Medicine, 1977
- Comparative Effectiveness of Combinations of Amikacin with Penicillin G and Amikacin with Carbenicillin in Gram-Negative Septicemia: Double-Blind Clinical TrialThe Journal of Infectious Diseases, 1976
- Differential Sensitivity of Herpes Simplex Virus Types 1 and 2 to Human Interferon: Antiviral Effects of Interferon plus 9- -D-ArabinofuranosyladenineThe Journal of Infectious Diseases, 1976
- ASCORBIC ACID ENHANCEMENT OF DESFERRIOXAMINE‐INDUCED URINARY IRON EXCRETION IN THALASSEMIA MAJOR*Annals of the New York Academy of Sciences, 1974
- The Biochemistry of Desferrioxamine and its Relation to Iron MetabolismAnnals of the New York Academy of Sciences, 1964